Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California Irvine, California.
Am J Perinatol. 2024 Apr;41(6):677-683. doi: 10.1055/s-0043-1776902. Epub 2023 Nov 10.
In the setting of a growing obese obstetric population, we sought to determine whether differences in body mass index (BMI) and obesity class influenced both serum magnesium levels and the likelihood of achieving therapeutic levels for eclampsia prophylaxis after standard boluses of magnesium sulfate.
This is a retrospective cohort study of patients treated with magnesium sulfate in the setting of either preeclampsia with severe features or preterm labor between 2010 and 2016. Subjects were categorized by BMI: Normal (BMI < 30 kg/m), Class 1 (BMI 30-34.9 kg/m), Class 2 (BMI 35-39.9 kg/m), and Class 3 (BMI ≥ 40 kg/m). Study participants' demographics, intrapartum characteristics, and adverse reactions were compared among the groups. Logistic regression models were used to calculate unadjusted and adjusted odds ratios comparing the likelihood of each BMI class reaching therapeutic eclamptic prophylactic levels. Linear regression models were also evaluated to determine the relationship between BMI and post-bolus serum magnesium levels.
Of the 760 people who met the inclusion criteria, 313 (41.1%) had normal BMI, 190 (25.0%) had Class 1 obesity, 135 (17.8%) had Class 2 obesity, and 122 (16.1%) had Class 3 obesity. When adjusted for confounders, those with Class 1 obesity were 54% less likely to achieve serum levels deemed therapeutic for seizure prophylaxis compared with normal BMI counterparts. Meanwhile, those with Class 2 or 3 obesity were 90% less likely. Linear regression models also demonstrated an inverse association between BMI and post-bolus serum magnesium levels.
Increasing BMI has a significant effect on post-bolus serum magnesium levels regardless of standard loading dose used. Immediately after bolus administration, obese gravidas are significantly less likely to reach levels effective for eclamptic seizure prophylaxis. When considering which bolus to administer in an obese gravida, it may be more beneficial to choose a 6 g load.
· BMI has an inverse relationship with post-bolus serum magnesium levels.. · Obese gravidas were less likely to reach eclampsia prophylaxis levels regardless of bolus type.. · Obesity class, not just the presence or absence of obesity, plays a role in serum magnesium levels..
在肥胖产妇不断增加的情况下,我们旨在确定体重指数(BMI)和肥胖程度的差异是否会影响硫酸镁标准推注后血清镁水平和子痫前期预防的治疗水平。
这是一项回顾性队列研究,研究对象为 2010 年至 2016 年期间患有重度子痫前期或早产的硫酸镁治疗患者。受试者根据 BMI 分为:正常(BMI<30kg/m)、1 类(BMI 30-34.9kg/m)、2 类(BMI 35-39.9kg/m)和 3 类(BMI≥40kg/m)。比较了各组患者的人口统计学特征、产时特征和不良反应。使用逻辑回归模型计算未调整和调整后的优势比,比较每个 BMI 类别达到治疗性子痫前期预防水平的可能性。还评估了线性回归模型,以确定 BMI 与推注后血清镁水平之间的关系。
在符合纳入标准的 760 人中,313 人(41.1%)的 BMI 正常,190 人(25.0%)的 BMI 为 1 类肥胖,135 人(17.8%)的 BMI 为 2 类肥胖,122 人(16.1%)的 BMI 为 3 类肥胖。在校正混杂因素后,1 类肥胖患者与正常 BMI 患者相比,血清水平达到预防癫痫发作的治疗水平的可能性降低 54%。而 2 类或 3 类肥胖患者的可能性降低了 90%。线性回归模型还表明,BMI 与推注后血清镁水平之间存在反比关系。
无论使用何种标准负荷剂量,BMI 的增加都会对推注后血清镁水平产生显著影响。推注后立即,肥胖孕妇达到预防子痫发作的有效水平的可能性明显降低。在考虑给肥胖孕妇使用哪种推注时,选择 6g 负荷可能更有益。
· BMI 与推注后血清镁水平呈反比关系。
· 肥胖孕妇无论使用何种类型的推注,达到子痫前期预防水平的可能性均较低。
· 肥胖程度类别,而不仅仅是肥胖的存在与否,在血清镁水平中起作用。